Rritual Mushrooms Lauded for Attractive Product Marketing and Growth During Annual Awards

• Plant-based superfood developer Rritual Mushrooms Inc. has produced its initial product lineup of three functional mushroom elixirs and powders designed to boost personal wellness
• The company was recognized by retail marketing agency ECRM for its attractive product presentation and growing success, as judged by national outlets including CVS, Vitamin Shoppe, Amazon and Rite Aid
• The functional mushroom market is a nascent subsection of the wellness industry ripe with potential for companies that get in on the ground floor as expectations for the industry grow
• Rritual’s Reishi Relax, Chaga Immune and Lion’s Mane Focus formulations are available in 14-stick packs and in 250-gram tubs, as well as in a 14-day variety pack that includes all three elixirs

Lifestyle therapeutics innovator Rritual Mushrooms gained recognition for its development of attractive marketing and its growing market presence at the 2020 annual ECRM Buyer’s Choice Awards.

The awards spotlight Efficient Collaborative Retail Marketing, and Rritual Mushrooms achieved second place in the Whole Body & Mind Wellness category, which was voted on by wellness product buyers from national retail outlets in a virtual event last month (https://ibn.fm/xEIAx).

“Rritual’s performance at the ECRM Buyer’s Choice Awards was not only a vote of confidence for the long-term potential of our product line but also a clear indication that there is strong demand for high-quality and accessible mushroom products among mainstream consumers and retailers alike,” Rritual’s CEO David Kerbel stated.

Rritual Mushroom is a premium brand in the functional mushroom market, an industry that is still in its infancy and ripe with potential for early movers. Certain mushrooms have long been touted for their beneficial properties — as an example, the Reishi mushroom enjoys a reputation as “the mushroom of immortality” after thousands of years of use in traditional Chinese medicine for boosting the immune system, fighting off cancer, fatigue and depression, supporting heart health, and helping to control blood sugar levels (https://ibn.fm/T5mVn).

Rritual has introduced an initial product line of elixirs, shots and mixes for three mushroom varieties paired with select adaptogens — herbal substances used to increase the body’s ability to resist biological stress (https://ibn.fm/JzamN). In addition to Reishi, which is paired with the adaptogen Ashwagandha root, Rritual’s products pair the Chaga mushroom with Eleuthero root and the Lion’s Mane mushroom with Rhodiola root.

“I believe Rritual has a great business model and product portfolio, in addition to a talented and passionate management team that uniquely positions it for success in the emerging plant-based industry,” Dr. Mike Hart, the company’s new president stated when he was hired in June (https://ibn.fm/rQY5o). “Their mission to help people adapt to modern life and prove that mushrooms are one of the world’s greatest superfoods is a perfect fit with my own wellness practices as a physician, and personally as an individual who is passionate about mental and physical health.”

Each Reishi Relax, Chaga Immune and Lion’s Mane Focus elixir also contains a blend of six functional mushrooms including turkey tail, shiitake and maitake, as well as a prebiotic blend featuring inulin and lucuma fruit powder, which together are designed to support immune and digestive health.

ECRM VP of Health and Beauty Care Craig Chmielowicz noted the timeliness of Rritual’s product offering, stating, “A big part of wellness these days — especially during the pandemic — includes finding ways to relax the body and mind” (https://ibn.fm/tO6y8).

For more information, visit the company’s website at https://Investors.WeAreRritual.com.

“Mental Fitness is a Daily Ritual”

NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at http://ibn.fm/Rritual

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.